OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid ยท OpenFeds ยท OpenSpending

ยฉ 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodologyโ€ขDownload Data
  1. Home
  2. Providers
  3. Richard Cherny
๐ŸŽ—๏ธ
MDIndividual

Richard Cherny, M.D.

NPI: 1659351484
East Syracuse, NY
10 years of data
Hematology-Oncology
$27.0M
Total Payments
483
Beneficiaries
2.0M
Services
2.8x
Markup Ratio

Peer Comparison

99th
percentile in specialty
This provider$27.0M
Specialty median$339.6K

๐Ÿ“‹ Key Findings

1Billed $27.0M over 10 years
22.8x markup ratio (above median)
399th percentile in Hematology-Oncology by payments
4792 services/day โ€” physically implausible
5Payments surged 400% in 2018
64 procedures with >3x markup

โš ๏ธ This provider averages 792 services per working day โ€” physically unusual for an individual practitioner

Based on 2.0M total services over 10 years (250 working days/year). Learn about impossible service volumes โ†’

๐Ÿ”Ž Data Analysis

This provider's $27.0M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.

Averaging 792 services per working day raises questions about billing patterns.

Medicare payments to this provider grew 1095% from 2014 to 2023.

AI-generated analysis based on Medicare payment data.

Annual Medicare Payments

Annual Services Provided

Avg Payment per Service

Markup Ratio Over Time

๐Ÿ“ˆ

Notable: Payments increased 400% in 2018

Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.

Submitted Charges vs. Medicare Payments

Average per-service amounts submitted by the provider compared to what Medicare actually paid โ€” the gap represents the markup.

YearAvg SubmittedAvg PaidMarkup RatioGap per ServiceTotal PaymentsServicesBeneficiaries
2014$51.71$15.523.33x$36.19$524.2K33.8K39
2015$40.88$13.453.04x$27.43$264.3K19.6K30
2016$33.65$13.132.56x$20.52$272.9K20.8K30
2017$36.05$14.282.52x$21.77$266.5K18.7K32
2018$40.56$14.112.87x$26.45$1.3M94.3K48
2019$34.47$12.582.74x$21.89$1.6M129.6K54
2020$35.78$12.582.84x$23.20$4.3M338.2K64
2021$40.38$14.622.76x$25.76$6.1M418.1K63
2022$37.15$13.262.80x$23.89$6.1M457.4K63
2023$38.96$13.962.79x$25.00$6.3M449.0K60

Top Procedures (20)

J9271Injection, pembrolizumab, 1 mg
$5.6M
137.6K services$40.94/svc2.25x markup
J9299Injection, nivolumab, 1 mg
$3.6M
154.8K services$23.03/svc2.44x markup
J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj
$2.1M
57.4K services$36.79/svc2.31x markup
J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
$1.5M
43.6K services$34.68/svc2.35x markup
J9022Injection, atezolizumab, 10 mg
$1.2M
19.6K services$63.78/svc2.23x markup
J2505Injection, pegfilgrastim, 6 mg
$1.2M
444 services$2.7K/svc2.70x markup
J0897Injection, denosumab, 1 mg
$1.1M
64.6K services$16.40/svc2.56x markup
J1930Injection, lanreotide, 1 mg
$970.7K
20.0K services$48.44/svc2.52x markup
J9305Injection, pemetrexed, not otherwise specified, 10 mg
$882.0K
20.2K services$43.67/svc2.79x markup
J9041Injection, bortezomib, 0.1 mg
$697.7K
24.7K services$28.20/svc2.77x markup
J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)โš  4.7x markup
$609.0K
227.6K services$2.68/svc4.66x markup
G9678Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
$585.3K
3.7K services$158.32/svc1.05x markup
99214Established patient office or other outpatient visit, 30-39 minutes
$559.3K
6.7K services$83.36/svc2.60x markup
Q5119Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mgโš  3.1x markup
$512.4K
11.9K services$43.01/svc3.14x markup
96413Administration of chemotherapy into vein, 1 hour or lessโš  3.3x markup
$508.9K
4.8K services$105.41/svc3.34x markup
J9173Injection, durvalumab, 10 mg
$308.7K
5.0K services$62.13/svc2.22x markup
J9264Injection, paclitaxel protein-bound particles, 1 mg
$303.0K
27.9K services$10.86/svc2.30x markup
J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
$267.3K
2.4K services$109.48/svc2.91x markup
99213Established patient office or other outpatient visit, 20-29 minutes
$255.0K
4.5K services$56.64/svc2.54x markup
J1439Injection, ferric carboxymaltose, 1 mgโš  4.6x markup
$212.8K
247.1K services$0.86/svc4.64x markup
Show detailed table โ–พ
CodeDescriptionServicesPaymentsAvg/ServiceMarkup
J9271Injection, pembrolizumab, 1 mg137.6K$5.6M$40.942.25x
J9299Injection, nivolumab, 1 mg154.8K$3.6M$23.032.44x
J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj57.4K$2.1M$36.792.31x
J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg43.6K$1.5M$34.682.35x
J9022Injection, atezolizumab, 10 mg19.6K$1.2M$63.782.23x
J2505Injection, pegfilgrastim, 6 mg444$1.2M$2.7K2.70x
J0897Injection, denosumab, 1 mg64.6K$1.1M$16.402.56x
J1930Injection, lanreotide, 1 mg20.0K$970.7K$48.442.52x
J9305Injection, pemetrexed, not otherwise specified, 10 mg20.2K$882.0K$43.672.79x
J9041Injection, bortezomib, 0.1 mg24.7K$697.7K$28.202.77x
J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)227.6K$609.0K$2.684.66x
G9678Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a3.7K$585.3K$158.321.05x
99214Established patient office or other outpatient visit, 30-39 minutes6.7K$559.3K$83.362.60x
Q5119Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg11.9K$512.4K$43.013.14x
96413Administration of chemotherapy into vein, 1 hour or less4.8K$508.9K$105.413.34x
J9173Injection, durvalumab, 10 mg5.0K$308.7K$62.132.22x
J9264Injection, paclitaxel protein-bound particles, 1 mg27.9K$303.0K$10.862.30x
J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg2.4K$267.3K$109.482.91x
99213Established patient office or other outpatient visit, 20-29 minutes4.5K$255.0K$56.642.54x
J1439Injection, ferric carboxymaltose, 1 mg247.1K$212.8K$0.864.64x

Markup Analysis

Charge-to-Payment Ratio

2.8x

This provider submits charges 2.8 times higher than what Medicare actually pays.

What This Means

A markup ratio of 2.8x means for every $100 Medicare pays, this provider initially charges $280. This is higher than the national average.

Location

East Syracuse, NY

Provider Verification

Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.

Related

Browse
โ† Back to Provider Directory
State
All providers in NY โ†’
Specialty
All Hematology-Oncology providers โ†’
Tool
Compare this provider โ†’
Analysis
Fraud Watchlist โ†’
Search
Search all providers โ†’

Share This Provider

Share this provider's Medicare payment information

Share:

Data Sources

  • โ€ข Centers for Medicare & Medicaid Services (CMS)
  • โ€ข Medicare Provider Utilization and Payment Data (2014-2023)
  • โ€ข National Plan and Provider Enumeration System (NPPES)

Last Updated: February 2026 (data through 2023, the latest CMS release)

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.

Believe this data is inaccurate? Dispute this data